Aluminum (Al) is the third-most abundant element found in the earth's crust and occurs naturally in the environment, foodstuffs, and drinking water ([@kfy081-B48]). Although the concentration of Al in drinking water and foods has been low, the levels of Al in drinking water are increased by acid rain ([@kfy081-B54]). Conversely, Al products have many modern applications. Adding aluminum sulfate and lime to water causes aluminum hydroxide formation, which leads to settling of pollutants. Al-containing agents are also commonly found as food and medication additives. Infant formulae are especially rich in Al ([@kfy081-B10]). Human exposure to Al usually occurs primarily by way of the gastrointestinal tract through oral intake. In a 60-kg adult, estimated daily alimentary Al exposure is 1.6--13 mg (0.2--1.5 mg/kg body weight \[BW\]/week); however, relative exposure in children is higher at up to 2.3 mg/kg BW/week ([@kfy081-B16]).

Absorbed Al can cross the blood-brain barrier and accumulate in the brain, especially in hippocampal tissue ([@kfy081-B56]). The neurotoxic effect of Al is well known and excessive Al exposure causes multiple abnormalities of the neuronal system, especially in uremic patients with dialytic treatment, called dementia-like encephalopathy, with features similar to Alzheimer's disease ([@kfy081-B15]). In addition, mothers and their newborn infants showed nearly identical blood Al concentration in the analysis of human biological samples ([@kfy081-B57]), and prolonged intravenous feeding with solutions containing Al has been shown to be associated with impaired neurologic development in preterm infants ([@kfy081-B7]). Experimentally, maternal Al exposure results in a high concentration of Al in the hippocampus in neonatal rats ([@kfy081-B62]), and oral Al exposure during lactation has been shown to cause neurotoxicity, such as short- and long-term memory deficits in rats ([@kfy081-B40]).

The dentate gyrus in the hippocampal formation of the mammalian brain is crucial for higher brain functions, such as learning, memory, and motivation ([@kfy081-B41]). During postnatal life, neurogenesis continues in the subgranular zone (SGZ) of the dentate gyrus ([@kfy081-B63]). In the SGZ, type-1 neural stem cells (NSCs) differentiate into type-2a, type-2b, and type-3 progenitor cells. The type-3 cells undergo final mitosis to differentiate into immature granule cells, and then to mature granule cells ([@kfy081-B28]). In the hilus of the dentate gyrus, subpopulations of γ-aminobutyric acid (GABA)-ergic interneurons innervate granule cell lineage populations to control neurogenesis in the SGZ ([@kfy081-B39]). One subpopulation of GABAergic interneurons produces Reelin, an extracellular glycoprotein that is essential for neuronal migration and correct positioning, including that for the granule cell lineage ([@kfy081-B23]). In addition to GABAergic neuronal inputs, various types of neurons outside the SGZ also create a synaptic connection with neurons in the dentate gyrus, such as glutamatergic neurons in the entorhinal cortex providing axonal projections to the dentate gyrus ([@kfy081-B20]) and cholinergic neurons originating from the septal nucleus and nucleus of the diagonal band of Broca innervating neurons in the hilus of the dentate gyrus ([@kfy081-B5]). Glutamatergic inputs to the SGZ are important for maintaining proper proliferation and differentiation of the granule cell lineage ([@kfy081-B21]).

Recently, we reported that developmental exposure of several neurotoxicants and developmental neurotoxicants, such as manganese, acrylamide, and glycidol, targets granule cell lineages to alter a number of subpopulations during hippocampal neurogenesis ([@kfy081-B52]). In addition to the changes in granule cell lineage subpopulations, we have also detected aberrations in the number of hilar GABAergic interneuron subpopulations ([@kfy081-B52]). With regard to neuronal signals from outside the hippocampus to the neurons in the dentate gyrus, we also reported decreased glutamatergic or cholinergic inputs in association with disrupted neurogenesis ([@kfy081-B29]; [@kfy081-B58]). Therefore, evaluating the effects of toxicants on neurogenesis by analyzing populations of granule cell lineages in combination with interneuron subpopulations, as well as fluctuations in signal inputs, could reveal target mechanisms involved in neurogenesis.

In the present study, to determine whether exogenously administered Al targets developing nervous systems, we examined the maternal exposure effect of aluminum chloride (AlCl~3~) on developmental neurotoxicity, targeting hippocampal neurogenesis in mouse offspring. We analyzed distribution changes of granule cell lineage subpopulations in the SGZ/GCL, as well as their cell proliferation, apoptosis and synaptic plasticity. We also analyzed distribution changes of GABAergic interneuron subpopulations in the hilus of the dentate gyrus, as well as transcript expression changes of other regulatory systems.

MATERIALS AND METHODS
=====================

### 

#### Chemicals and animals

Aluminum chloride hexahydrate (AlCl~3~·6H~2~O; purity: \>98.0%; CAS No. 7784-13-6) was purchased from Wako Pure Chemical Industries, Ltd (Osaka, Japan). Thirty-six mated female Slc: ICR mice were purchased from Japan SLC, Inc (Hamamatsu, Japan) at gestational day (GD) 1 (appearance of vaginal plug was designated as GD 0). Maternal animals were individually housed in polycarbonate cages with paper bedding until postnatal day (PND) 21 (where PND 0 is the day of delivery). Animals were maintained in an air-conditioned animal room (temperature: 23 ± 2°C, relative humidity: 55 ± 15%) with a 12-h light/dark cycle. Maternal animals were allowed access to a pelleted basal diet (CRF-1; Oriental Yeast Co. Ltd, Tokyo, Japan) throughout the experimental period and distilled water (DW) *ad libitum* until the start of exposure to AlCl~3~. From PND 21 onwards, offspring were reared with 2 or 3 animals per cage and provided with the pellet CRF-1 basal diet and DW *ad libitum*.

#### Experimental design

Mated female mice were randomly assigned to 3 groups of 12 animals per group by stratified randomization according to BW and treated with 0, 900, or 1800 ppm AlCl~3~ (0, 182, or 364 ppm as Al) in DW from GD 6 to PND 21 ([Supplementary Figure 1](#sup1){ref-type="supplementary-material"}). Based on the appearance of behavioral abnormalities of mouse offspring by postnatal exposure to AlCl~3~ during PND 1--15 via maternal drinking water at the dose level of ≥300 mg/kg body weight/day ([@kfy081-B2]), a preliminary maternal exposure study, which was consisted of the dosing groups similar to or exceeding the level to induce behavioral abnormalities, ie, 0, 600, and 1200 ppm in the drinking water, was conducted (*N* = 5 dams). At 1200 ppm, male offspring exposed to AlCl~3~ showed transient decrease in the body weight on PND 5 and female offspring decreased absolute brain weight on PND 21. There were no apparent changes in the number of live offspring and body weight of dams at both 600 and 1200 ppm. Thus, we decided to select 1800 ppm as the highest dose level that is expected to show slight maternal toxicity, according to the Organisation for Economic Co-operation and Development (OECD) guideline for the testing of chemicals (Test No. 426: Developmental Neurotoxicity Study; [@kfy081-B45]). The lower dose was subsequently set to 900 ppm.

Body weights and food and water consumption of dams were measured twice a week throughout the experimental period. On PND 4, the litters were randomly culled to preserve 5--7 male pups and 3--5 female pups per litter. The offspring were weighed every twice a week until PND 21.

In the present study, male offspring were selected for immunohistochemical and gene expression analyses, because neurogenesis is influenced by circulating levels of steroid hormones during the estrous cycle ([@kfy081-B47]). On PND 21, 10--12 male offspring per group (1 male offspring per dam) were subjected to perfusion fixation for histopathological assessment and immunohistochemistry through the left cardiac ventricle with ice-cold 4% (w/v) paraformaldehyde (PFA) in 0.1 M phosphate buffer (pH 7.4) at a flow rate of 10 ml/min after deep anesthetization with CO~2~/O~2~. For gene expression analysis, 20--24 male offspring per group (2 male pups per dam) were euthanized by exsanguination from the abdominal aorta under CO~2~/O~2~ anesthesia and subjected to necropsy, and brains were fixed in methacarn solution at 4°C for 5 h after measuring the weight. All dams were euthanized by exsanguination from the abdominal aorta under CO~2~/O~2~ anesthesia and their brains were removed to fix with Bouin's solution and neutral buffered formalin (pH 7.4), respectively at 4°C overnight. Twenty-24 female offspring per group (2 female pups per dam) were also similarly euthanized for collection of brain samples to store at --20°C for other experimental purposes after measuring the weight. The remaining offspring were maintained without administration of AlCl~3~ until PND 77, and body weight was measured once a week.

On PND 77, 10--12 male offspring per group (1 male offspring per dam) were subjected to perfusion fixation with 4% PFA buffer solution for histopathological assessment and immunohistochemistry at a flow rate of 10 ml/min. For gene expression analysis, 13--22 male offspring per group (1 or 2 male pups per dam) were euthanized by exsanguination from the abdominal aorta under CO~2~/O~2~ anesthesia and subjected to necropsy, and brains were fixed in methacarn solution at 4°C for 5 h after measuring the weight. Six male offspring of 1800 ppm group and 16--28 female offspring per group (1--3 female pups per dam) were also similarly euthanized for collection of brain samples to store at --20°C for other experimental purposes after measuring the weight. All animal experiments were conducted in accordance with the "Guidelines for Proper Conduct of Animal Experiments" (Science Council of Japan, June 1, 2006), and the protocols were approved by the Animal Care and Use Committee of the Tokyo University of Agriculture and Technology. All efforts were made to minimize animal suffering.

#### Histopathology of the brain

After fixation with 4% PFA buffer solution at PND 21 and PND 77, brains from male offspring (*N* = 10--12/group; 1 male pups per dam) were additionally immersion fixed with the same solution overnight at 4°C. Three-mm-thick coronal slices were prepared at −2.2 mm from the bregma. Brain slices were further immersion fixed with 4% PFA buffer solution overnight at 4°C and were routinely processed for paraffin embedding and sectioned into 3-μm-thick sections. Brain sections were stained with hematoxylin and eosin and subjected to histopathological examination.

#### Immunohistochemistry and apoptotic cell detection in the brain

Brain sections of male offspring perfused at necropsies on PND 21 and PND 77 were also subjected to immunohistochemistry using primary antibodies against proliferating cell nuclear antigen (PCNA), and the neuronal stage-defining markers, glial fibrillary acidic protein (GFAP), expressed in type-1 NSCs (radial glial cells) in the SGZ ([@kfy081-B31]), sex determining region Y-box 2 (SOX2), expressed in type-1 NSCs, type-2a and type-2b progenitor cells ([@kfy081-B37]), T-box brain protein 2 (TBR2), expressed in type-2b progenitor cells in the SGZ ([@kfy081-B37]), and doublecortin (DCX), expressed in type-2b and type-3 progenitor cells and immature granule cells in the SGZ and GCL ([@kfy081-B31]; [@kfy081-B37]) and neuron-specific nuclear protein (NeuN), expressed in postmitotic neurons of both immature and mature granule cells in the SGZ and GCL ([@kfy081-B31]; [@kfy081-B37]). Immunohistochemistry of GABAergic interneuron subpopulations was also performed using primary antibodies against Reelin, parvalbumin (PVALB), calbindin-D-28K (CALB1) and somatostatin (SST) ([@kfy081-B21]; [@kfy081-B23]). Immunohistochemistry of glutamatergic excitatory mossy cells was performed using primary antibody against calbindin-D-29K (CALB2; [@kfy081-B22]). Immunohistochemistry of molecules related to synaptic plasticity was also performed using primary antibodies against FBL osteosarcoma oncogene (FOS), activity-regulated cytoskeleton-associated protein (ARC), and cyclooxygenase-2 (COX-2), which are the members of immediate-early genes (IEGs) involved in neuronal plasticity ([@kfy081-B19]; [@kfy081-B25]; [@kfy081-B43]). Immunohistochemistry of molecules related to cell cycle was also performed using primary antibodies against p21^Cip1/Waf1^, a cyclin-dependent kinase inhibitor acting in G~1~/S phase ([@kfy081-B50]). Immunohistochemistry of molecules related to astrocyte, microglia, and oligodendrocyte was also performed using primary antibodies against GFAP, an intermediate filament expressed in astrocytes ([@kfy081-B17]); ionized calcium-binding adaptor molecule 1 (Iba1), a specific marker of microglia ([@kfy081-B30]); and oligodendrocyte transcription factor 2 (OLIG2), a specific marker of oligodendrocyte ([@kfy081-B18]). Incubation with the respective antibodies was performed overnight at 4°C. Primary antibodies are listed in the [Supplementary Table 1](#sup1){ref-type="supplementary-material"}. Deparaffinized sections were incubated in 0.3% hydrogen peroxide solution in absolute methanol for 30 min to quench endogenous peroxidase. Conditions of antigen retrieval applied for some antibodies were shown in [Supplementary Table 1](#sup1){ref-type="supplementary-material"}. Immunodetection was performed using a Vectastain Elite ABC kit (Vector Laboratories, Burlingame, CA) with DAB/H~2~O~2~ as the chromogen. Immunostained sections were then counterstained with hematoxylin and coverslipped for microscopic examination. One section per animal was subjected to each immunohistochemistry.

For evaluation of apoptosis in the SGZ or GCL of the dentate gyrus, a terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay was carried out using the ApopTag Peroxidase In situ Apoptosis Detection kit (EMD Millipore, Billerica, MA) according to the manufacturer's instructions, with DAB/H~2~O~2~ as the chromogen. One section per animal was subjected to TUNEL assay.

#### Morin (3,5,7,2′,4′-pentahydroxyflavone) staining

The Al-Morin fluorescence assay was performed for visualization and detection of Al in the SGZ/GCL, according to the protocol by [@kfy081-B51]. Brain sections from 5 male pups per group were stained with Morin, a fluorochrome that forms a fluorescent complex with Al fluorescing green with an excitation wavelength of 420 nm ([@kfy081-B13]; [@kfy081-B14]). Deparaffinized sections were first washed with phosphate buffered saline (pH 7.4) twice for 5 min, and then pretreated for 10 min in a 1% aqueous solution of hydrochloric acid, rinsed in DW twice for 5 min, and immersed in 0.2% solution of Morin (Sigma-Aldrich, St. Luis, MO) in 85% ethyl alcohol containing 0.5% acetic acid for 10 min. The sections were then washed in DW twice for 5 min, dehydrated in 70%, 90%, and 100% ethyl alcohol, cleared with 100% xylene, and mounted with Bioleit (Oken-shoji, Tokyo, Japan). One section per animal was subjected to Al-Morin fluorescence assay.

#### Morphometry of immunolocalized cells, apoptotic cells, and Morin-stained cells

All immunoreactive cells, ie, GFAP^+^, SOX2^+^, TBR2^+^, DCX^+^, NeuN^+^, ARC^+^, COX-2^+^, FOS^+^, PCNA^+^, or p21^Cip1/Waf1+^ cells, and all TUNEL^+^ apoptotic cells in the SGZ and/or GCL of whole dentate gyrus were bilaterally counted and normalized for the entire length of the SGZ ([Supplementary Figure 2](#sup1){ref-type="supplementary-material"}). GFAP^+^ radial glia cells were morphologically identified as those having cell bodies that reside in the SGZ and vertical processes that extend into the molecular layer of the dentate gyrus and distinguished from GFAP^+^ astrocytes in the hilus of the hippocampal dentate gyrus. All immunoreactive cells distributed within the hilus, ie, Reelin^+^, PVALB^+^, CALB1^+^, CALB2^+^, SST^+^, NeuN^+^, GFAP^+^, Iba1^+^, or OLIG2^+^ cells were bilaterally counted and normalized per unit area of the whole hilar area ([Supplementary Figure 2](#sup1){ref-type="supplementary-material"}). The immunoreactive cells were analyzed by blind trial for the treatment conditions. Cornu ammonis region 3 pyramidal neurons distributed in the hilar area were easily distinguished from hilar interneurons and excluded from counting. For quantitative measurements of each immunoreactive cellular component, digital photomicrographs at 400-fold magnification were taken using a BX53 microscope (Olympus Corp., Tokyo, Japan) attached to a DP72 Digital Camera System (Olympus Corp.), and quantitative measurements were performed using the WinROOF image analysis software package (version 5.7, Mitani Corp., Fukui, Japan).

Detection of the fluorescent complex of Morin with Al was performed as reported previously ([@kfy081-B33]) with some modification. To acquire Morin-fluorescence images, BX-53 fluorescence microscope (Olympus Corp.) equipped with a color charge-coupled device camera (DP72; Olympus Corp.) and cellSens imaging software (Olympus Corp.) were used. The excitation and emission filter was 400 to 440 and 460 nm (long pass), respectively. The green channel images corresponding to Morin-fluorescence were used to count the Morin^+^ cells, following the subtraction of background of fluorescence to normalize sample-to-sample variation. All Morin^+^ cells in the GCL of whole dentate gyrus were bilaterally counted and normalized for the entire length of the SGZ ([Supplementary Figure 2](#sup1){ref-type="supplementary-material"}).

#### Real-time reverse-transcription polymerase chain reaction

Real-time reverse-transcription polymerase chain reaction (RT-PCR) analysis of transcript expression in the hippocampal dentate gyrus was examined in PND 21 and PND 77 offspring. Brain tissues were dissected according to the whole-brain fixation method using methacarn solution ([@kfy081-B3]). In brief, 2-mm-thick coronal cerebral slices were prepared at −2.2 mm from the bregma after methacarn-fixation. Hippocampal dentate gyrus tissue was collected from the slice using a punch biopsy device with a 1-mm pore size (Kai Industries Co. Ltd, Gifu, Japan). Total RNA was extracted from tissue samples of the 0-ppm controls and 1800-ppm AlCl~3~-exposed groups (N = 6 pups from different dams per group) using QIAzol (Qiagen, Hilden, Germany) and RNeasy Mini kit (Qiagen) according to the manufacturer's protocol. First-strand cDNA was synthesized using SuperScript III Reverse Transcriptase (Thermo Fisher Scientific, Waltham, MA) from 2 μg total RNA. Analysis of the transcript levels for gene targets shown in [Supplementary Table 2](#sup1){ref-type="supplementary-material"} was performed with the PCR primers designed with Primer Express software (Version 3.0; Thermo Fisher Scientific). Real-time PCR with Power SYBR Green PCR Master Mix (Thermo Fisher Scientific) was conducted using individual samples (N = 6) and a StepOnePlus Real-time PCR System (Thermo Fisher Scientific). At first, comparison of the expression level was made between 0-ppm controls and 1800-ppm AlCl~3~ group, and the relative differences in gene expression between the 2 groups were calculated with threshold cycle (*C*~T~) values that were first normalized to those of the glyceraldehyde 3-phosphate dehydrogenase (*Gapdh*) or hypoxanthine guanine phosphoribosyl transferase (*Hprt*) gene as the endogenous control in the same sample. The relative differences in gene expression compared with control *C*~T~ values were calculated using the 2^−ΔΔ*C*^~T~ method as previously described ([@kfy081-B36]).

#### Statistical analysis

Numerical data are presented as mean ± SD. Maternal body weights, food and water consumption, and organ weights were analyzed using the individual animal as the experimental unit. Offspring body and organ weights, immunoreactive cell counts for each antigen, and numbers of apoptotic cells were analyzed using the litter as the experimental unit. Data were analyzed using the Levene's test for homogeneity of variance. Significant differences between the 0-ppm controls and each AlCl~3~-exposed group were evaluated as follows. If the variance was homogenous, numerical data were assessed using the Dunnett's test. For heterogeneous data, the Aspin-Welch's *t*-test with Bonferroni correction was applied. Numerical data consisting of 2 sample groups were analyzed using the Student's *t*-test when the variance was homogenous between the groups, and the Aspin-Welch's *t*-test was performed when data were heterogeneous. All analyses were performed using the IBM SPSS Statistics ver. 25 (IBM Japan, Ltd, Tokyo, Japan).

RESULTS
=======

### Maternal Parameters

One nonpregnant animal in the 900-ppm group and 2 animals which had abortions, one each in the 900-ppm and 1800-ppm group, as confirmed by examination of implantation sites and the number of live offspring at birth, were excluded from the experiment. Therefore, effective number of dams were 12, 10, and 11 for 0-, 900-, and 1800-ppm group, respectively. The number of implantation sites and live offspring and male ratio were not different between the 0-ppm controls and the AlCl~3~-exposed groups ([Supplementary Table 3](#sup1){ref-type="supplementary-material"}). Dams showed no significant changes in body weight during gestation and lactation periods between the 0-ppm and any of the exposed groups ([Figure 1](#kfy081-F1){ref-type="fig"}). Food consumption was significantly decreased on PND 2 in the 900- and 1800-ppm groups and on PND 19 in the 1800-ppm group compared with 0-ppm controls ([Figure 1](#kfy081-F1){ref-type="fig"}). Water consumption was significantly decreased from PND 9 to PND 21 in the 900-ppm group, and from GD 17 to PND 21 in the 1800-ppm group, compared with 0-ppm controls ([Figure 1](#kfy081-F1){ref-type="fig"}). There were no abnormalities in the gait and behaviors of dams in any group. At necropsy on PND 21, there were no change in absolute and relative brain weights in any group ([Supplementary Table 3](#sup1){ref-type="supplementary-material"}). Based on mean values of water consumption, dams in the 900- and 1800-ppm groups received 107.9 and 207.1 mg/kg body weight/day Al, respectively, during the gestation period. Dams took 319.8 and 574.5 mg/kg body weight/day Al during the lactation period, respectively.

![Body weight (A), food consumption (B), and water consumption (C) of dams during the exposure period. \**p* \< .05, \*\**p* \< .01, compared with the 0-ppm controls by Dunnett's test or Aspin-Welch's *t*-test with Bonferroni correction.](kfy081f1){#kfy081-F1}

### Clinical Observation and Necropsy Data of Offspring

No abnormalities in the gait and behaviors were observed in offspring of any group before necropsy on PND 21 and after weaning. Body weights of male offspring of the 1800-ppm group significantly decreased from PND 4 to PND 77 compared with 0-ppm controls. Body weights of female offspring of the 900-ppm group from PND 4 to PND 12 and from PND 19 to PND 35 and of the 1800-ppm group from PND 4 to PND 56 significantly decreased compared with 0-ppm controls ([Supplementary Table 4](#sup1){ref-type="supplementary-material"}). At necropsy on PND 21, male offspring of the 1800-ppm group and female offspring of the 900- and 1800-ppm groups showed significantly decreased body weight compared with 0-ppm controls ([Table 1](#kfy081-T1){ref-type="table"}). At necropsy on PND 77, male offspring of the 1800-ppm group showed significantly decreased body weight compared with 0-ppm controls. With regard to brain weight in male offspring on PND 21, relative weight was significantly higher in the 1800-ppm group compared with 0-ppm controls ([Table 1](#kfy081-T1){ref-type="table"}). In female offspring, absolute weight was significantly lower in the 1800-ppm group and relative weight was significantly higher in the 900- and 1800-ppm groups, compared with 0-ppm controls. With regard to brain weight in male offspring on PND 77, absolute and relative weights showed no change in any group. In female offspring, absolute brain weight was significantly lower in the 1800-ppm group compared with 0-ppm controls. Table 1.Body and Brain Weights of Offspring on PND 21 and PND 77AlCl~3~ in Drinking Water (ppm)0 (Control)9001800PND 21 Males  No. of offspring examined363033   Body weight (g)17.9 ± 0.916.9 ± 1.315.6 ± 0.8[\*\*](#tblfn4){ref-type="table-fn"}  No. of offspring examined242022   Brain weight (g)0.45 ± 0.020.44 ± 0.010.43 ± 0.01         (g/100g body weight)2.50 ± 0.152.65 ± 0.262.79 ± 0.18[\*\*](#tblfn4){ref-type="table-fn"} Females  No. of offspring examined242022   Body weight (g)17.4 ± 0.715.7 ± 1.5[\*\*](#tblfn4){ref-type="table-fn"}15.1 ± 0.7[\*\*](#tblfn4){ref-type="table-fn"}   Brain weight (g)0.44 ± 0.010.43 ± 0.010.43 ± 0.02[\*](#tblfn3){ref-type="table-fn"}         (g/100g body weight)2.58 ± 0.192.82 ± 0.24[\*](#tblfn3){ref-type="table-fn"}2.90 ± 0.13[\*\*](#tblfn4){ref-type="table-fn"}PND 77 Males  No. of offspring examined322339   Body weight (g)53.0 ± 2.853.0 ± 4.748.3 ± 2.1[\*\*](#tblfn4){ref-type="table-fn"}  No. of offspring examined201328   Brain weight (g)0.50 ± 0.010.50 ± 0.020.50 ± 0.02         (g/100g body weight)0.98 ± 0.080.94 ± 0.101.04 ± 0.08 Females  No. of offspring examined282716   Body weight (g)42.5 ± 4.443.7 ± 2.740.5 ± 3.4   Brain weight (g)0.51 ± 0.020.49 ± 0.020.48 ± 0.03[\*](#tblfn3){ref-type="table-fn"}         (g/100g body weight)1.85 ± 0.081.89 ± 0.091.95 ± 0.17[^1][^2][^3][^4]

### Brain Histopathology of Male Offspring

There were no histopathological changes in the brain of male offspring in any group at both PND 21 and PND 77.

### Distribution of Granule Cell Lineage Subpopulations in the SGZ and GCL of Male Offspring

On PND 21, the number of GFAP^+^ cells in the SGZ was significantly less at 900 ppm, and the number of TBR2^+^ cells in the SGZ and DCX^+^ cells in the SGZ/GCL was significantly greater at 1800 ppm compared with 0-ppm controls ([Figure 2](#kfy081-F2){ref-type="fig"}). With regard to SOX2^+^ cells in the SGZ and NeuN^+^ cells in the GCL, there were no significant differences in any exposure group compared with 0-ppm controls. On PND 77, the number of GFAP^+^ cells in the SGZ was significantly less at 1800 ppm ([Figure 2](#kfy081-F2){ref-type="fig"} and [Supplementary Figure 3](#sup1){ref-type="supplementary-material"}). However, no significant differences were observed in the number of SOX2^+^ cells and TBR2^+^ cells in the SGZ, and DCX^+^ cells in the SGZ/GCL, and NeuN^+^ cells in the GCL of any exposure group compared with 0-ppm controls.

![Distribution of immunoreactive cells for (A) glial fibrillary acidic protein (GFAP), (B) SRY (sex determining region Y)-box2 (SOX2), and (C) T box brain protein 2 (TBR2) in the subgranular zone (SGZ), (D) doublecortin (DCX) in the SGZ and granule cell layer (GCL), and (E) neuron-specific nuclear protein (NeuN) in the GCL of male offspring at postnatal day (PND) 21 and PND 77 after maternal exposure to aluminum chloride (AlCL~3~) from gestational day (GD) 6 to PND 21. Representative images from the 0-ppm controls (left), and the 900-ppm (middle), and 1800-ppm (right) AlCL~3~ groups at PND 21. Magnification ×400; bar 50 μm. Graphs show the numbers of immunoreactive cells in the SGZ and/or GCL. *N* = 9--12/group (PND 21: 0-ppm controls, 10; 900-ppm AlCL~3~, 10; 1800-ppm AlCL~3~, 10; PND 77: 0-ppm controls, 12; 900-ppm AlCL~3~, 9; 1800-ppm AlCL~3~, 11). \**p* \< .05, compared with the 0-ppm controls by Dunnett's test or Aspin-Welch's *t*-test with Bonferroni correction.](kfy081f2){#kfy081-F2}

### Distribution of Neuronal Subpopulations in the Hilus of the Dentate Gyrus of Male Offspring

On PND 21, the number of Reelin^+^ cells in the hilus was significantly less at 1800 ppm compared with 0-ppm controls, and the number of PVALB^+^ cells was significantly greater at 1800 ppm compared with 0-ppm controls ([Figure 3](#kfy081-F3){ref-type="fig"}). There were no significant differences in the number of CALB1^+^ cells, CALB2^+^ cells and SST^+^ cells and NeuN^+^ postmitotic neurons of any exposure group compared with 0-ppm controls ([Figure 3](#kfy081-F3){ref-type="fig"} and [Supplementary Figures 4 and 5](#sup1){ref-type="supplementary-material"}). On PND 77, the number of Reelin^+^ cells was significantly less at ≥900 ppm compared with 0-ppm controls ([Figure 3](#kfy081-F3){ref-type="fig"} and [Supplementary Figure 6](#sup1){ref-type="supplementary-material"}). No significant differences were observed in the numbers of PVALB^+^ cells, CALB1^+^ cells, CALB2^+^ cells, SST^+^ cells and NeuN^+^ mature neurons of any exposure group compared with 0-ppm controls ([Figure 3](#kfy081-F3){ref-type="fig"} and [Supplementary Figures 4--6](#sup1){ref-type="supplementary-material"}).

![Distribution of interneurons immunoreactive for (A) Reelin or (B) parvalbumin (PVALB), and (C) NeuN-immunoreactive postmitotic neurons in the hilus of the hippocampal dentate gyrus of male offspring at PND 21 and PND 77 after maternal exposure to aluminum chloride (AlCL~3~) from GD 6 to PND 21. Representative images from the 0-ppm controls (left) and the 900-ppm (middle) and 1800-ppm (right) AlCL~3~ groups at PND 21. Magnification ×400; bar 50 μm. Graphs show the numbers of immunoreactive interneurons in the hilus. *N* = 9--12/group (PND 21: 0-ppm controls, 10; 900-ppm AlCL~3~, 10; 1800-ppm AlCL~3~, 10; PND 77: 0-ppm controls, 12; 900-ppm AlCL~3~, 9; 1800-ppm AlCL~3~, 11). \**p* \< .05, \*\**p *\< .01, compared with the 0-ppm controls by Dunnett's test or Aspin-Welch's *t*-test with Bonferroni correction.](kfy081f3){#kfy081-F3}

### Proliferating, Apoptotic and Cycle-Arrested Cells in the SGZ and GCL of Male Offspring

On PND 21, there was no significant difference in the number of PCNA^+^ proliferating cells and TUNEL^+^ apoptotic cells in the SGZ in any exposure group compared with 0-ppm controls ([Figure 4](#kfy081-F4){ref-type="fig"}). On the other hand, the number of TUNEL^+^ apoptotic cells in the GCL was significantly greater at 900 ppm compared with 0-ppm controls. The number of p21^Cip1/Waf1+^ cells in the SGZ was significantly less at ≥900 ppm compared with 0-ppm controls. On PND 77, no significant differences were observed in the number of PCNA^+^ cells in the SGZ, TUNEL^+^ cells in the SGZ or GCL and p21^Cip1/Waf1+^ cells in the SGZ in any exposure group compared with 0-ppm controls ([Figure 4](#kfy081-F4){ref-type="fig"} and [Supplementary Figure 7](#sup1){ref-type="supplementary-material"}).

![Distribution of (A) proliferating cell nuclear antigen (PCNA)^+^ proliferating cells in the SGZ, (B) terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL)^+^ apoptotic cells in the SGZ or the GCL, and (C) p21^Cip1/Waf1+^ cells in the SGZ of male offspring at PND 21 and PND 77 after maternal exposure to aluminum chloride (AlCL~3~) from GD 6 to PND 21. Representative images from the 0-ppm controls (left) and the 900-ppm (middle) and 1800-ppm (right) AlCL~3~ groups at PND 21. Arrowheads indicate immunoreactive or TUNEL^+^ apoptotic cells. Magnification ×400; bar 50 μm. Graphs show the numbers of immunoreactive cells in the SGZ or GCL. In the graphs of (B), left and right columns at each dose indicate the numbers of TUNEL^+^ cells in the SGZ and in the GCL, respectively. *N* = 9--12/group (PND 21: 0-ppm controls, 10; 900-ppm AlCL~3~, 10; 1800-ppm AlCL~3~, 10; PND 77: 0-ppm controls, 12; 900-ppm AlCL~3~, 9; 1800-ppm AlCL~3~, 11). \**p* \< .05, \*\**p* \< .01, compared with the 0-ppm controls by Dunnett's test or Aspin-Welch's *t*-test with Bonferroni correction.](kfy081f4){#kfy081-F4}

### Distribution of Synaptic Plasticity-Related Molecules in the GCL of Male Offspring

On PND 21, the number of COX-2^+^ cells in the GCL was significantly greater at ≥900 ppm compared with 0-ppm controls, whereas there were no significant differences in the numbers of ARC^+^ cells and FOS^+^ cells in any exposure group compared with 0-ppm controls ([Figure 5](#kfy081-F5){ref-type="fig"}). On PND 77, no significant differences were observed in the numbers of FOS^+^ cells, ARC^+^ cells and COX-2^+^ cells in any exposure group compared with 0-ppm controls ([Figure 5](#kfy081-F5){ref-type="fig"} and [Supplementary Figure 8](#sup1){ref-type="supplementary-material"}).

![Distribution of immunoreactive cells for (A) FBJ osteosarcoma oncogene (FOS), (B) activity-regulated cytoskeleton-associated protein (ARC), and (C) cyclooxygenase-2 (COX-2) in the GCL of the hippocampal dentate gyrus of male offspring at PND 21 and PND 77 after maternal exposure to aluminum chloride (AlCL~3~) from GD 6 to PND 21. Representative images from the 0-ppm controls (left) and the 900-ppm (middle) and 1800-ppm (right) AlCL~3~ groups at PND 21. Magnification ×400; bar 50 μm. Graphs show the numbers of immunoreactive cells in the GCL. *N* = 9--12/group (PND 21: 0-ppm controls, 10; 900-ppm AlCL~3~, 10; 1800-ppm AlCL~3~, 10; PND 77: 0-ppm controls, 12; 900-ppm AlCL~3~, 9; 1800-ppm AlCL~3~, 11). \*\**p* \< .01, compared with the 0-ppm controls by Dunnett's test or Aspin-Welch's *t*-test with Bonferroni correction.](kfy081f5){#kfy081-F5}

### Morin^+^ Cells in the SGZ/GCL of Male Offspring

On PND 21, Morin^+^ cells were observed in the GCL in addition to the SGZ in AlCl~3~-exposed offspring, whereas Morin^+^ cells were observed mainly in the SGZ in 0-ppm controls ([Figure 6](#kfy081-F6){ref-type="fig"}). The number of Morin^+^ cells was significantly higher at ≥900 ppm compared with 0-ppm controls. On PND 77, no significant differences in the number of Morin^+^ cells were observed in any exposure group compared with 0-ppm controls ([Figure 6](#kfy081-F6){ref-type="fig"}).

![Distribution of Morin^+^ cells in the SGZ/GCL of the hippocampal dentate gyrus of male offspring at PND 21 and PND 77 after maternal exposure to aluminum chloride (AlCL~3~) from GD 6 to PND 21. Representative images from the 0-ppm controls (left) and the 900-ppm (middle) and 1800-ppm (right) AlCL~3~ groups at PND 21. Magnification ×400; bar 50 μm. Graphs show the numbers of Morin^+^ cells in the GCL. *N* = 5/group. \**p* \< .05, \*\**p* \< .01, compared with the 0-ppm controls by Dunnett's test or Aspin-Welch's *t*-test with Bonferroni correction.](kfy081f6){#kfy081-F6}

### Distribution of Astrocytes, Microglia and Oligodendrocytes in the Hilus of the Dentate Gyrus of Male Offspring

On PND 21, there were no significant differences in the numbers of GFAP^+^ cells, Iba1^+^ cells and OLIG2^+^ cells in the hilus of any exposure group compared with 0-ppm controls ([Supplementary Figures 9 and 10](#sup1){ref-type="supplementary-material"}). On PND 77, the number of Iba1^+^ cells was significantly greater at 900 ppm compared with 0-ppm controls ([Supplementary Figures 9 and 10](#sup1){ref-type="supplementary-material"}). No significant differences were observed in the number of GFAP^+^ cells and OLIG2^+^ cells of any exposure group compared with 0-ppm controls.

### Transcript Expression Changes in the Dentate Gyrus of Male Offspring

Transcript expression level was compared between 0-ppm controls and 1800-ppm group on PND 21 and PND 77 ([Table 2](#kfy081-T2){ref-type="table"}). With regard to synaptic plasticity-related genes, expression level of *Arc* significantly increased after normalization with *Hprt* at 1800 ppm compared with 0-ppm controls on PND 21 and decreased after normalization with *Gapdh* and *Hprt* at 1800 ppm compared with 0-ppm controls on PND 77. With regard to cell proliferation-related *Pcna*, expression level significantly decreased after normalization with *Gapdh* and *Hprt* at 1800 ppm compared with 0-ppm controls on PND 21 and with *Gapdh* at 1800 ppm compared with 0-ppm controls on PND 77. With regard to cholinergic receptor genes, transcript expression levels of *Chrna4* significantly decreased after normalization with *Gapdh* at 1800 ppm compared with 0-ppm controls on PND 21. With regard to genes of glutamate transporters and receptors, expression level of *Slc17a6* significantly decreased after normalization with *Gapdh* and *Hprt* at 1800 ppm compared with 0-ppm controls on PND 21 and increased after normalization with *Hprt* at 1800 ppm compared with 0-ppm controls on PND 77. Expression levels of *Gria3* and *Grin2a* significantly increased after normalization with *Hprt* at 1800 ppm compared with 0-ppm controls on PND 21. In contrast, *Grin2d* expression levels significantly decreased after normalization with *Gapdh* at 1800 ppm compared with 0-ppm controls on PND 21 and increased after normalization with *Hprt* at 1800 ppm compared with 0-ppm controls on PND 77. With regard to apoptosis-related genes, expression level of *Bax* significantly decreased after normalization with *Gapdh* at 1800 ppm compared with 0-ppm controls on PND 21 and PND 77. Expression level of *Casp12* significantly increased after normalization with *Hprt* at 1800 ppm compared with 0-ppm controls on PND 21. Expression level of *Casp2* significantly increased after normalization with *Hprt* at 1800 ppm compared with 0-ppm controls on PND 77. Other genes listed in [Table 2](#kfy081-T2){ref-type="table"} did not show significant fluctuations in transcript expression levels between 0-ppm controls and the 1800-ppm group on both PND 21 and PND 77. Table 2.Real-time RT-PCR Analysis Data in the Hippocampal Dentate Gyrus on PND 21 and PND 770 ppm AlCl~3~ (Control)1800 ppm AlCl~3~Relative Transcript Level Normalized toRelative Transcript Level Normalized to*GapdhHprtGapdhHprt* No. of animals examined^*a*^6666PND 21 Synaptic plasticity  *Arc*1.02 ± 0.231.04 ± 0.321.63 ± 0.871.83 ± 0.80[\*](#tblfn7){ref-type="table-fn"}  *Ptgs2*1.02 ± 0.241.01 ± 0.130.78 ± 0.150.89 ± 0.10  *Fos*1.02 ± 0.211.02 ± 0.240.98 ± 0.311.14 ± 0.38 Stem cell regulation  *Kitl*1.02 ± 0.251.04 ± 0.320.78 ± 0.191.02 ± 0.37  *Notch1*1.03 ± 0.281.07 ± 0.420.89 ± 0.291.14 ± 0.43 Cell proliferation  *Pcna*1.01 ± 0.151.00 ± 0.060.71 ± 0.15[\*\*](#tblfn8){ref-type="table-fn"}0.81 ± 0.12[\*\*](#tblfn8){ref-type="table-fn"} Neurotrophic action  *Ntrk2*1.03 ± 0.291.09 ± 0.520.98 ± 0.191.29 ± 0.45  *Bdnf*1.07 ± 0.421.08 ± 0.481.21 ± 0.281.60 ± 0.60 Cholinergic receptors  *Chrna7*1.03 ± 0.301.04 ± 0.341.13 ± 0.391.29 ± 0.35  *Chrna4*1.01 ± 0.171.07 ± 0.430.66 ± 0.25[\*](#tblfn7){ref-type="table-fn"}0.82 ± 0.28  *Chrnb2*1.02 ± 0.201.02 ± 0.200.82 ± 0.110.95 ± 0.13 Glutamate transporters/receptors  *Slc17a6*1.05 ± 0.411.05 ± 0.370.47 ± 0.22[\*](#tblfn7){ref-type="table-fn"}0.58 ± 0.21[\*](#tblfn7){ref-type="table-fn"}  *Slc17a7*1.12 ± 0.631.15 ± 0.761.94 ± 0.972.19 ± 0.89  *Gria1*1.09 ± 0.531.10 ± 0.481.12 ± 0.281.44 ± 0.47  *Gria2*1.10 ± 0.501.09 ± 0.531.52 ± 0.592.00 ± 0.93  *Gria3*1.03 ± 0.251.02 ± 0.221.37 ± 0.441.56 ± 0.39[\*](#tblfn7){ref-type="table-fn"}  *Grin2a*1.07 ± 0.411.07 ± 0.451.77 ± 0.692.36 ± 1.13[\*](#tblfn7){ref-type="table-fn"}  *Grin2d*1.02 ± 0.241.11 ± 0.520.55 ± 0.14[\*\*](#tblfn8){ref-type="table-fn"}0.70 ± 0.15 Apoptosis  *Bax*1.01 ± 0.181.01 ± 0.110.78 ± 0.13[\*](#tblfn7){ref-type="table-fn"}0.89 ± 0.09  *Bcl2*1.02 ± 0.201.00 ± 0.081.06 ± 0.321.22 ± 0.30  *Casp2*1.01 ± 0.171.02 ± 0.221.02 ± 0.231.16 ± 0.17  *Casp3*1.04 ± 0.281.04 ± 0.310.97 ± 0.121.27 ± 0.36  *Casp9*1.02 ± 0.181.01 ± 0.160.95 ± 0.161.09 ± 0.14  *Casp12*1.02 ± 0.201.02 ± 0.211.21 ± 0.281.38 ± 0.22[\*](#tblfn7){ref-type="table-fn"}PND 77 Synaptic plasticity  *Arc*1.02 ± 0.211.01 ± 0.180.36 ± 0.14[\*\*](#tblfn8){ref-type="table-fn"}0.45 ± 0.15[\*\*](#tblfn8){ref-type="table-fn"}  *Ptgs2*1.06 ± 0.441.01 ± 0.180.79 ± 0.380.96 ± 0.25  *Fos*1.01 ± 0.121.02 ± 0.180.79 ± 0.310.98 ± 0.18 Stem cell regulation  *Kitl*1.14 ± 0.541.33 ± 0.551.49 ± 0.921.74 ± 0.80  *Notch1*1.02 ± 0.241.01 ± 0.350.91 ± 0.351.14 ± 0.22 Cell proliferation  *Pcna　*1.02 ± 0.201.01 ± 0.160.72 ± 0.22[\*](#tblfn7){ref-type="table-fn"}0.92 ± 0.15 Neurotrophic action  *Ntrk2*1.02 ± 0.261.00 ± 0.090.86 ± 0.341.07 ± 0.17  *Bdnf*1.05 ± 0.391.04 ± 0.290.92 ± 0.261.17 ± 0.10 Cholinergic transporters/receptors  *Chrna7　*1.07 ± 0.481.04 ± 0.320.89 ± 0.271.13 ± 0.17  *Chrna4*1.13 ± 0.601.13 ± 0.581.45 ± 0.711.75 ± 0.45  *Chrnb2　*1.04 ± 0.301.03 ± 0.301.10 ± 0.491.34 ± 0.28 Glutamate receptors  *Slc17a6*1.26 ± 0.821.26 ± 0.872.37 ± 1.352.82 ± 0.98[\*](#tblfn7){ref-type="table-fn"}  *Slc17a7*1.11 ± 0.621.06 ± 0.390.79 ± 0.161.03 ± 0.10  *Gria1*1.07 ± 0.471.04 ± 0.301.02 ± 0.281.31 ± 0.15  *Gria2*1.04 ± 0.331.03 ± 0.260.81 ± 0.191.05 ± 0.14  *Gria3*1.06 ± 0.441.01 ± 0.180.86 ± 0.311.11 ± 0.14  *Grin2a*1.08 ± 0.521.05 ± 0.341.04 ± 0.291.33 ± 0.21  *Grin2d*1.10 ± 0.521.07 ± 0.441.60 ± 0.971.91 ± 0.71[\*](#tblfn7){ref-type="table-fn"} Apoptosis  *Bax*1.02 ± 0.251.00 ± 0.080.72 ± 0.15[\*](#tblfn7){ref-type="table-fn"}0.93 ± 0.08  *Bcl2*1.05 ± 0.311.04 ± 0.290.82 ± 0.450.99 ± 0.35  *Casp2*1.02 ± 0.251.01 ± 0.191.12 ± 0.481.41 ± 0.35[\*](#tblfn7){ref-type="table-fn"}  *Casp3*1.02 ± 0.241.01 ± 0.170.89 ± 0.361.11 ± 0.22  *Casp9*1.04 ± 0.371.01 ± 0.161.02 ± 0.451.27 ± 0.27  *Casp12*1.09 ± 0.521.03 ± 0.270.94 ± 0.361.22 ± 0.38[^5][^6][^7][^8]

DISCUSSION
==========

In the present study, we observed decreases of GFAP^+^ type-1 NSCs at 900 ppm and p21^Cip1/Waf1+^ SGZ cells at ≥900 ppm and hilar Reelin^+^ cells at 1800 ppm on PND 21. We also observed statistically non-significant decrease of GFAP^+^ type-1 NSCs at 1800 ppm. The p21^Cip1/Waf1^ induces cell cycle arrest at the G~1~/S checkpoint to maintain relative quiescence ([@kfy081-B50]). The loss of p21^Cip1/Waf1^ expression increases NSC proliferation by compromising cell quiescence, especially under stress conditions ([@kfy081-B35]; [@kfy081-B49]). Then, the loss of p21^Cip1/Waf1^ expression leads to self-renewal exhaustion and progressive decline in NSC proliferation rate by slowing down of cell cycling ([@kfy081-B35]). In addition, Reelin-deficiency in reeler mice causes decreased proliferation of NSCs in the hippocampus, suggesting that Reelin functions to maintain NSC proliferation ([@kfy081-B53]). Therefore, it may be possible to consider that AlCl~3~ causes p21^Cip1/Waf1^ downregulation to trigger a reduction of the NSC pool, and then downregulation of Reelin in interneurons to weaken NSC proliferation at the developmental stage. We also found *Pcna* transcript downregulation at 1800 ppm on PND 21, suggesting that AlCl~3~ exposure leads to NSCs slowing down cell cycling. Importantly, decreases of GFAP^+^ NSCs, *Pcna* transcript level, and Reelin^+^ cells were sustained through the adult stage on PND 77. We also observed a tendency to decrease p21^Cip1/Waf1+^ cells on PND 77. These results suggest an irreversible effect on hippocampal neurogenesis by developmental AlCl~3~ exposure.

In the present study, we observed increases of TBR2^+^ and DCX^+^ cells, reflecting increase of type-2 and type-3 progenitor cells and immature granule cells, in the SGZ/GCL, and also increase of hilar PVALB^+^ cells at 1800 ppm on PND 21. PVALB^+^ GABAergic interneurons have been shown to promote differentiation of type-2 progenitor cells ([@kfy081-B21]; [@kfy081-B59]), suggesting an increase of PVALB^+^ interneuron signals to cause an increase of TBR2^+^ and DCX^+^ cells. We also found transcript upregulation of *Grin2a*, which encodes one of the *N*-methyl-[d]{.smallcaps}-aspartate receptor (NMDAR) subunits, ie, NR2A, at 1800 ppm on PND 21. NR2A is essential to maintaining PVALB expression in GABAergic interneurons ([@kfy081-B34]), suggesting that *Grin2a* transcript upregulation is evidence for increase of PVALB^+^ interneurons. We further observed an increase of GCL COX-2^+^ cells at ≥900 ppm on PND 21. Reportedly, COX-2 in mature granule cells activates cell proliferation by producing prostaglandin E2/EP2 signals in SGZ progenitor cells ([@kfy081-B38]). Moreover, *Ptgs2* knockout mice have decreased DCX^+^ cells ([@kfy081-B44]). Therefore, the increase of GCL COX-2^+^ cells observed here may cause an increase of progenitor cells during AlCl~3~ exposure. However, transcript levels of *Pcna* were decreased at the end of exposure, suggestive of the suppression of progenitor cell proliferation to adjust excessive progenitor cell proliferation at the developmental stage.

In the present study, we did not observe any change in the number of NeuN^+^ mature granule cells by developmental AlCl~3~ exposure, despite the increases of type-2b, type-3 and immature cells in the SGZ/GCL at 1800 ppm on PND 21. However, TUNEL^+^ apoptotic granule cells were increased at  ≥900 ppm on PND 21, whereas the increase was statistically insignificant at 1800 ppm. Therefore, a balance between the increases of the progenitor and immature granule cell population and loss of granule cells by apoptosis may result in an unchanged number of GCL NeuN^+^ cells on PND 21 by AlCl~3~-exposure. Conversely, we observed downregulation of *Ba*x, a Bcl-2 family gene that is able to initiate the intrinsic apoptosis pathway ([@kfy081-B24]), examined at 1800 ppm on PND 21. In contrast, we observed transcript upregulation of *Casp12* at 1800 ppm. Considering the crucial role of caspase 12 in the progression of endoplasmic reticulum (ER) stress-mediated apoptosis ([@kfy081-B61]), facilitation of ER stress-mediated apoptosis and suppression of the intrinsic pathway of apoptosis may result in a nonsignificant increase of granule cell apoptosis at 1800 ppm. Interestingly, Al-accumulated granule cells as evident by Morin-staining were dose-dependently increased at ≥900 ppm on PND 21. Neuronal cell apoptosis has been suggested in relation with their Al accumulation ([@kfy081-B1]; [@kfy081-B51]). Because Al can induce ER stress-mediated apoptosis ([@kfy081-B42]), an increase of granule cell apoptosis at ≥900 ppm may be related to the cytotoxic effect of accumulated Al in granule cells in the present study. At 1800 ppm, a protective mechanism, such as suppression of the BAX-mediated intrinsic pathway of apoptosis, may be predominated. On PND 77, AlCl~3~-exposed animals did not see an increase in Al-accumulated cells and apoptosis in the SGZ/GCL. Considering the functional role of *Casp2* as a potent activator of the downstream intrinsic pathway of apoptosis, downregulation of *Ba*x, irrespective of the upregulation of *Casp2*, suggested suppression of the intrinsic pathway of apoptosis at the adult stage. Detection of Morin^+^ cells in the SGZ of all groups including 0-ppm controls in the present study may be the reflection of basal Al accumulation in the brain of normal animals ([@kfy081-B6]).

In the present study, we observed transcript downregulation of *Grin2d* and *Chrna4* on PND 21 at 1800 ppm. GRIN2D is a subunit protein of NMDA receptors and CHRNA4 is a subunit of the neuronal nicotinic acetylcholine receptor, both being expressed in GABAergic interneurons ([@kfy081-B55]; [@kfy081-B60]), suggesting an involvement of both glutamatergic and cholinergic signals in GABAergic interneurons to indirectly affect neurogenesis. In contrast, *Grin2d* transcript level was increased on PND 77, probably reflecting a compensatory response against downregulation on PND 21. Although the functional involvement of CHRNA4 in the hippocampal neurogenesis is not reported, CHRNB2 has been shown to play an important role in regulating SGZ cell proliferation ([@kfy081-B27]). Therefore, the decreased CHRNA4 subunit may affect tetramerization involving CHRNB2 to cause downregulation of the nicotinic acetylcholine receptor in GABAergic interneurons at 1800 ppm on PND 21, resulting in insufficient inputs from hilar GABAergic interneurons to the SGZ.

Synaptic plasticity in the hippocampus as a cellular mechanism of learning and memory requires appropriate integration of glutamatergic excitatory and GABAergic inhibitory synaptic inputs ([@kfy081-B8]). In the present study, we observed transcript upregulation of *Arc* at 1800 ppm on PND 21. ARC is a member of the IEGs that play a role in the initial steps of neuronal plasticity including axonal and synaptic plasticities ([@kfy081-B25]). However, *Arc* transcript level turned to be suppressed on PND 77, suggestive of suppression of ARC-related synaptic plasticity. Interestingly, NMDA receptor activation upregulates ARC expression ([@kfy081-B4]). As aforementioned, AlCl~3~ exposure upregulated transcript of the glutamatergic receptor subunit of NR2A at 1800 ppm on PND 21, suggesting a relation to the transcript upregulation of *Arc* for increase of GCL synaptic plasticity.

In the present study, we found transcript upregulation of *Gria3* at 1800 ppm on PND 21. GRIA3, a subunit of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR), is reportedly found at excitatory synapses throughout the brain ([@kfy081-B46]). The cellular models of synaptic plasticity, especially of long-term potentiation, can be expressed by the synaptic insertion of AMPARs ([@kfy081-B32]). Conversely, ARC interacts with endocytic machinery to regulate AMPAR trafficking and contributes to late-phase synaptic plasticity and memory consolidation ([@kfy081-B12]). These results suggest that transcript upregulation of *Arc* may facilitate membrane trafficking of increased GRIA3 on PND 21 by developmental AlCl~3~ exposure, whereas the ARC^+^ granule cells did not fluctuate in number. COX-2 is another molecule regulating synaptic plasticity of GCL ([@kfy081-B11]), and the number of COX-2^+^ granule cells was increased at ≥900 ppm on PND 21 in the present study, suggestive of the increase of synaptic plasticity of GCL. In contrast, we also found transcript downregulation of *Slc17a6* on PND 21 at 1800 ppm. On PND 77, *Slc17a6* was upregulated in this group. The highest density of boutons expressing VGLUT2, a gene product of *Slc17a6*, of mossy cells makes an axonal projection to granule cells in the dentate gyrus ([@kfy081-B26]). Additionally, the highest levels of VGLUT2 are expressed in the hippocampus during the early postnatal stage to mediate glutamate release to support synaptogenesis that is necessary for hippocampal development ([@kfy081-B9]). These results suggest unbalanced synaptic plasticity changes within the dentate gyrus through the adult stage.

In conclusion, developmental exposure to AlCl~3~ via maternal drinking water decreased the NSCs in offspring, suggestive of a reflection of NSC pool exhaustion by loss of p21^Cip1/Waf1^-mediated compromised cell quiescence to cause an impaired self-renewal capacity of NSCs accompanying slowing down of cell cycling. Decrease in Reelin^+^ hilar GABAergic interneurons may also contribute to the NSC reduction. In contrast, increase of progenitor and immature granule cells suggested facilitation of transient progenitor cell proliferation and differentiation by enhancing the PVALB^+^ interneuron signal and COX-2-mediated signals during exposure. In addition, increase of apoptosis or Morin-stained cells in the GCL, together with *Casp12* transcript upregulation, suggested an induction of Al accumulation-related ER stress-mediated granule cell apoptosis. Transcript expression changes on cholinergic and glutamatergic signals and synaptic plasticity suggested contribution to disruptive neurogenesis. The NSC-targeting effects were sustained through the adult stage despite no sustained Al-accumulation. These results suggest that developmental AlCl~3~-exposure irreversibly affects postnatal hippocampal neurogenesis involving multiple functions in mice.
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[^1]: Abbreviations: PND, postnatal day; AlCl~3~, aluminum chloride.

[^2]: Data are expressed as the mean ± SD.

[^3]: *p* \< .05,

[^4]: *p *\< .01, compared with the 0-ppm controls by Dunnett's test or Aspin-Welch's *t*-test with Bonferroni correction.

[^5]: Abbreviations: *Arc*, activity-regulated cytoskeletal-associated protein; *Bax*, BCL2-associated X protein; *Bcl2*, B-cell leukemia/lymphoma 2; *Bdnf*, brain derived neurotrophic factor; *Casp2*, caspase 2; *Casp3*, caspase 3; *Casp9*, caspase 9; *Casp12*, caspase 12; *Chrna4*, cholinergic receptor nicotinic alpha polypeptide 4; *Chrna7*, cholinergic receptor nicotinic alpha polypeptide 7; *Chrnb2*, cholinergic receptor nicotinic beta polypeptide 2; *Fos*, FBJ osteosarcoma oncogene; *Gapdh*, glyceraldehyde-3-phosphate dehydrogenase; *Gria1*, glutamate receptor, ionotropic, AMPA1 (alpha 1); *Gria2*, glutamate receptor, ionotropic, AMPA2 (alpha 2); *Gria3*, glutamate receptor, ionotropic, AMPA3 (alpha 3); *Grin2a*, glutamate receptor, ionotropic, NMDA2A (epsilon 1); *Grin2d*, glutamate receptor, ionotropic, NMDA2D (epsilon 4); *Hprt*, hypoxanthine guanine phosphoribosyl transferase; *Kitl*, kit ligand; *Notch1*, notch 1; *Ntrk2*, neurotrophic tyrosine kinase, receptor, type 2; *Pcna*, proliferating cell nuclear antigen; *Ptgs2*, prostaglandin-endoperoxide synthase 2; *Slc17a6*, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6; *Slc17a7*, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7.

[^6]: Data are expressed as the mean ± SD.

[^7]: *p* \< .05,

[^8]: *p *\< .01, compared with the 0-ppm controls by Student's *t*-test or Aspin-Welch's *t*-test.
